The document discusses various drugs that can increase the force of myocardial contraction, known as positive inotropic drugs, including cardiac glycosides like digoxin, beta-adrenergic agonists, and phosphodiesterase inhibitors. It provides details on the mechanisms of action and effects of these drugs, such as how cardiac glycosides inhibit the sodium-potassium ATPase pump to increase intracellular calcium levels. A variety of conditions are also listed where these positive inotropic drugs may be used, including congestive heart failure, shock, and cardiac emergencies.